West Pharmaceutical Services, Inc.
US ˙ NYSE ˙ US9553061055

SecurityWST / West Pharmaceutical Services, Inc.
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in WST / West Pharmaceutical Services, Inc.

On November 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of West Pharmaceutical Services, Inc. (US:WST) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 2,090 shares of West Pharmaceutical Services, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -2,090 -100.00 0 -100.00
2025-08-14 2025-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,090 1,046 100.19 457 96.14 0.0013
2025-05-15 2025-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,044 -124 -10.62 234 -39.01 0.0008
2025-02-14 2024-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,168 94 8.75 383 18.63 0.0012
2024-11-14 2024-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,074 -16,875 -94.02 322 -94.55 0.0010
2025-02-25 2024-06-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 17,949 1,964 12.29 5,912 -6.53 0.0176
2024-08-14 2024-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 17,949 1,964 5,912 0.0176
2024-05-15 2024-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 15,985 -6,657 -29.40 6,325 -20.66 0.0190
2024-07-16 2023-12-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 22,642 -22,075 -49.37 7,973 -52.49 0.0257
2024-02-14 2023-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 22,642 -22,075 7,973 0.0156
2023-11-14 2023-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 44,717 -20,077 -30.99 16,778 -32.29 0.0590
2023-08-14 2023-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 64,794 19,370 42.64 24,782 57.46 0.0823
2023-05-15 2023-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 45,424 -99,871 -68.74 15,738 -53.98 0.0541
2023-02-14 2022-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 145,295 99,969 220.56 34,195 206.60 0.1234
2023-02-14 2022-09-30 13F/A-1 West Pharmaceutical Services COM 955306105 45,326 -72,706 -61.60 11,154 -68.75 0.0439
2022-11-14 2022-09-30 13F West Pharmaceutical Services COM 955306105 45,326 -72,706 11,153 0.0439
2023-02-14 2022-06-30 13F/A-1 West Pharmaceutical Services COM 955306105 118,032 -21,589 -15.46 35,689 -37.76 0.1323
2022-08-15 2022-06-30 13F West Pharmaceutical Services COM 955306105 118,032 -21,589 35,690 0.1323
2023-02-14 2022-03-31 13F/A-1 West Pharmaceutical Services COM 955306105 139,621 -21,689 -13.45 57,344 -24.21 0.1630
2022-05-13 2022-03-31 13F West Pharmaceutical Services COM 955306105 139,621 -21,689 57,344 0.1630
2022-02-14 2021-12-31 13F West Pharmaceutical Services COM 955306105 161,310 47,985 42.34 75,656 57.25 0.1934
2021-11-15 2021-09-30 13F West Pharmaceutical Services COM 955306105 113,325 -67,553 -37.35 48,112 -25.93 0.1350
2021-08-13 2021-06-30 13F/A-1 West Pharmaceutical Services COM 955306105 180,878 66,993 58.83 64,953 102.41 0.1831
2021-08-13 2021-06-30 13F West Pharmaceutical Services COM 955306105 180,878 66,993 64,953 0.1097
2021-05-14 2021-03-31 13F West Pharmaceutical Services COM 955306105 113,885 -7,953 -6.53 32,090 -7.03 0.0977
2021-02-12 2020-12-31 13F West Pharmaceutical Services COM 955306105 121,838 56,549 86.61 34,517 92.32 0.1083
2021-02-11 2020-09-30 13F/A-1 West Pharmaceutical Services COM 955306105 65,289 -35,799 -35.41 17,948 -21.85 0.0649
2020-11-13 2020-09-30 13F West Pharmaceutical Services COM 955306105 65,289 -35,799 17,948 35,827.0566
2021-02-12 2020-06-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 101,088 31,288 44.83 22,965 116.10 0.0905
2020-08-14 2020-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 101,088 31,288 22,965 90,565.8288
2021-02-12 2020-03-31 13F/A-2 WEST PHARMACEUTICAL SVSC COM 955306105 69,800 54,900 368.46 10,627 374.42 0.0531
2020-06-15 2020-03-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 69,800 0 10,627 0.0532
2020-05-15 2020-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 69,800 54,900 10,627 29,553.8698
2021-02-12 2019-12-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 14,900 14,900 2,240 0.0091
2020-02-18 2019-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 14,900 2,240 0.0091
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.